Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1999;30:2448-2455

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Melani, A.
Right arrow Articles by von Lubitz, D. K. J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Melani, A.
Right arrow Articles by von Lubitz, D. K. J. E.

(Stroke. 1999;30:2448-2455.)
© 1999 American Heart Association, Inc.


Original Contributions

Striatal Outflow of Adenosine, Excitatory Amino Acids, {gamma}-Aminobutyric Acid, and Taurine in Awake Freely Moving Rats After Middle Cerebral Artery Occlusion

Correlations With Neurological Deficit and Histopathological Damage

Alessia Melani, BSci; Leonardo Pantoni, MD, PhD; Claudia Corsi, PhD; Loria Bianchi, PhD; Angela Monopoli, PhD; Rosalia Bertorelli, PhD; Giancarlo Pepeu, MD Felicita Pedata, PhD

From the Departments of Preclinical and Clinical Pharmacology (A. Melani, C.C., L.B., G.P., F.P.) and Neurological and Psychiatric Sciences (L.P.), University of Florence, and Schering-Plough Research Institute, Milan (A. Monopoli, R.B.), Italy.

Correspondence to Felicita Pedata, Department of Preclinical and Clinical Pharmacology, University of Florence, V.le Pieraccini 6, 50139 Florence, Italy. E-mail pedata{at}server1.pharm.unifi.it

Background and Purpose—While a number of studies have investigated transmitter outflow in anesthetized animals after middle cerebral artery occlusion (MCAO) performed by craniectomy, studies have never been performed after MCAO induced by intraluminal filament. In addition, it has been reported that after MCAO, infarct volume correlates with functional outcome and with transmitter outflow, although there are no studies that demonstrate a direct correlation between transmitter outflow and functional outcome. The purpose of the present study was to assess excitatory amino acids, {gamma}-aminobutyric acid, taurine, and adenosine outflow in awake rats after intraluminal MCAO and to determine whether, in the same animal, outflow was correlated with neurological outcome and histological damage.

Methods—Vertical microdialysis probes were placed in the striatum of male Wistar rats. After 24 hours, permanent MCAO was induced by the intraluminal suture technique. The transmitter concentrations in the dialysate were determined by high-performance liquid chromatography. Twenty-four hours after MCAO, neurological deficit and histological outcome were evaluated.

Results—All transmitters significantly increased after MCAO. Twenty-four hours after MCAO, the rats showed a severe sensorimotor deficit and massive ischemic damage in the striatum and in the cortex (9±2% and 25±6% of hemispheric volume, respectively). Significant correlations were found between the efflux of all transmitters, neurological score, and striatal infarct volume.

Conclusions—In this study, for the first time, amino acid and adenosine extracellular concentrations during MCAO by the intraluminal suture technique were determined in awake and freely moving rats, and a significant correlation was found between transmitter outflow and neurological deficit. The evaluation of neurological deficit, histological damage, and transmitter outflow in the same animal may represent a useful approach for studying neuroprotective properties of new drugs/agents against focal ischemia.

Editorial Comment

Correlations With Neurological Deficit and Histopathological Damage

Dag K. J. E. von Lubitz, MD, Guest Editor

Emergency Medicine Research Laboratories, Department of Emergency Medicine, University of Michigan Health System, Ann Arbor, Michigan




This article has been cited by other articles:


Home page
BrainHome page
A. Melani, S. Cipriani, M. G. Vannucchi, D. Nosi, C. Donati, P. Bruni, M. G. Giovannini, and F. Pedata
Selective adenosine A2a receptor antagonism reduces JNK activation in oligodendrocytes after cerebral ischaemia
Brain, June 1, 2009; 132(6): 1480 - 1495.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
I. Markovic, M. Segal, B. Djuricic, and Z. Redzic
Kinetics of nucleoside uptake by the basolateral side of the sheep choroid plexus epithelium perfused in situ
Exp Physiol, March 1, 2008; 93(3): 325 - 333.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. Shen, G.-J. Chen, B. K. Harvey, P. C. Bickford, and Y. Wang
Inosine Reduces Ischemic Brain Injury in Rats
Stroke, March 1, 2005; 36(3): 654 - 659.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
T. Nariai, Y. Shimada, K. Ishiwata, T. Nagaoka, J. Shimada, T. Kuroiwa, K.-I. Ono, K. Ohno, K. Hirakawa, and M. Senda
PET Imaging of Adenosine A1 Receptors with 11C-MPDX as an Indicator of Severe Cerebral Ischemic Insult
J. Nucl. Med., November 1, 2003; 44(11): 1839 - 1844.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
D. Centonze, E. Saulle, A. Pisani, G. Bernardi, and P. Calabresi
Adenosine-mediated inhibition of striatal GABAergic synaptic transmission during in vitro ischaemia
Brain, September 1, 2001; 124(9): 1855 - 1865.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. D. Mongan, J. Capacchione, J. L. Fontana, S. West, and R. Bunger
Pyruvate improves cerebral metabolism during hemorrhagic shock
Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H854 - H864.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. Serena, R. Leira, J. Castillo, J. M. Pumar, M. Castellanos, and A. Davalos
Neurological Deterioration in Acute Lacunar Infarctions : The Role of Excitatory and Inhibitory Neurotransmitters
Stroke, May 1, 2001; 32(5): 1154 - 1161.
[Abstract] [Full Text] [PDF]